Clinical trials recruiting for Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• "The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"
  NCT06679387 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• A Composite Assay for HER2-positive Early-stage Breast Cancer Management
  NCT06762977 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer
  NCT06781996 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening
  NCT07273357 · Phase: Not specified · Ages: 70 Years and older · Sex: All (male and female) · 5 locations
• Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer
  NCT07373782 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 80 Years · Sex: Female · 1 location
• Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy
  NCT06823414 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
  NCT06800612 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
  NCT06807502 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX
  NCT06723990 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
  NCT06917313 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 2 locations
• Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome.
  NCT07206394 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.
  NCT07387445 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 99 Years · Sex: Female · 2 locations
• Impact of PErioperative Nutrition Intervention on Bioimpedance Phase Angle (IPENIPA) In Breast Cancer Patients
  NCT06890221 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year
  NCT06930521 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 79 Years · Sex: All (male and female) · 1 location
• Multimodal Prehabilitation Program That Combines Physical Exercise, Psychological Intervention and Nutritional Support to Improve the Response to Neoadjuvant Chemoterhapy in Early Breast Cancer Patients
  NCT07107594 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 2 locations
• Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC
  NCT07797218 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Outcomes of a Novel Technique Minimal Scar Mastectomy
  NCT06676761 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 2 locations
• PARTial BREast RECONstruction With Chest Wall Perforator Flap
  NCT06728527 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
  NCT06927180 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy
  NCT06885671 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: Female · 1 location
• Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy
  NCT06902051 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: Female · 2 locations
• Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
  NCT07331506 · Phase: Not specified · Ages: 40 Years to 70 Years · Sex: Female · 1 location
• ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
  NCT06970912 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location

Related conditions

Trials recruiting for Breast Cancer Early Stage Breast Cancer (Stage 1-3) often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Breast Cancer Early Stage Breast Cancer (Stage 1-3) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.